
Tazlive Trio 40mg/5mg/12.5mg Tablet
Marketer
Allysia Lifesciences Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Tazlive Trio 40mg/5mg/12.5mg Tablet
Tri-Med Hypertension 40mg/5mg/12.5mg tablets combine three medications to effectively manage hypertension when monotherapy proves insufficient. This regimen lowers elevated blood pressure, thereby mitigating the risk of future strokes and heart attacks. Administer Tri-Med Hypertension with or without food, as directed by your physician; dosage is individualized. Maintain consistent daily timing. Continuous use, as prescribed, is crucial; premature discontinuation elevates stroke and heart attack risk. The formulation includes a diuretic, potentially increasing urination; avoid dosing within four hours of bedtime. Consistent use maximizes therapeutic benefits, even in the absence of noticeable symptoms (as hypertension is often asymptomatic). Common side effects include fatigue, headache, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinusitis. Report persistent, worsening, or bothersome side effects to your doctor. Adequate hydration is recommended to counter potential side effects such as dry mouth, thirst, and muscle weakness. Prior to initiating treatment, disclose any liver or kidney issues, and pregnant or breastfeeding individuals should seek medical counsel. Inform your physician of all concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to ensure optimal therapeutic efficacy.
Uses of Tazlive Trio 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Tazlive Trio 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tazlive Trio 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. This medicine can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Tazlive Trio 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Tazlive Trio 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tazlive Trio 40mg/5mg/12.5mg Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Tazlive Trio 40mg/5mg/12.5mg Tablet works:
The combined medication Tazlive Trio (40mg/5mg/12.5mg tablets) comprises telmisartan, amlodipine, and hydrochlorothiazide. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, act synergistically to dilate blood vessels, thus reducing blood pressure. Hydrochlorothiazide, a diuretic, promotes fluid excretion, decreasing blood volume and further lowering blood pressure via enhanced vascular relaxation and improved blood flow.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Tazlive Trio 40mg/5mg/12.5mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Tazlive Trio 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Concurrent use of Tazlive Trio 40mg/5mg/12.5mg tablets and breastfeeding is contraindicated due to potential infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Tazlive Trio 40mg/5mg/12.5mg Tablet side effects. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Tazlive Trio 40mg/5mg/12.5mg tablets, as dose modification may be necessary. Physician consultation is advised. Tazlive Trio 40mg/5mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Tazlive Trio 40mg/5mg/12.5mg Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tazlive Trio 40mg/5mg/12.5mg Tablet :
Should you forget a dose of Tazlive Trio 40mg/5mg/12.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tazlive Trio 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | HEART |
